mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.8 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.8 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.8 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.9 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.9 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |